Walleye Capital’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-14,171
Closed -$328K 4847
2026
Q1
$339K Buy
+14,171
New +$346K ﹤0.01% 2976
2025
Q4
Sell
-20,965
Closed -$456K 4690
2025
Q3
$422K Buy
+20,965
New +$351K ﹤0.01% 2752
2025
Q2
Sell
-49,908
Closed -$583K 4622
2025
Q1
$524K Sell
49,908
-84,062
-63% -$951K ﹤0.01% 2518
2024
Q4
$1.62M Sell
133,970
-58,982
-31% -$772K ﹤0.01% 1971
2024
Q3
$2.83M Buy
192,952
+187,523
+3,454% +$2.61M 0.01% 1630
2024
Q2
$78.3K Sell
5,429
-2,841
-34% -$45.4K ﹤0.01% 4809
2024
Q1
$135K Sell
8,270
-75,674
-90% -$1.18M ﹤0.01% 4216
2023
Q4
$1.25M Buy
+83,944
New +$951K ﹤0.01% 2171
2023
Q3
Sell
-66,722
Closed -$775K 4984
2023
Q2
$671K Buy
66,722
+55,279
+483% +$513K ﹤0.01% 2203
2023
Q1
$108K Buy
+11,443
New +$135K ﹤0.01% 2886
2022
Q4
Sell
-150,854
Closed -$1.88M 3297
2022
Q3
$1.87M Buy
+150,854
New +$2.64M 0.04% 602
2019
Q4
Sell
-200
Closed -$5.43K 1909
2019
Q3
$5K Sell
200
-1,400
-88% -$42K ﹤0.01% 1808
2019
Q2
$54K Buy
+1,600
New +$51.9K 0.01% 1369

Other funds holding ELAN

Walleye Capital's ELAN Position: Q2 2026 in Review

Walleye Capital sold out of Elanco Animal Health (ELAN) in Q2 2026, closing a stake of 14,171 shares — an estimated $328K sold.

Walleye Capital first reported a position in ELAN in Q2 2019 and held it in 13 quarters. The position peaked at $2.83M in Q3 2024. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Walleye Capital reported no remaining Elanco Animal Health position as of Q2 2026 after selling out during the quarter.
  • Walleye Capital sold 14,171 Elanco Animal Health shares in Q2 2026, an estimated $328K.
  • Walleye Capital first reported a position in Elanco Animal Health in Q2 2019 and held it in 13 quarters.
  • Walleye Capital's Elanco Animal Health position peaked at $2.83M in Q3 2024.
  • 523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.